 RED BANK, N.J. , July 28, 2022 PRNewswire -- Provention Bio, Inc. Nasdaq: PRVB, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its second quarter 2022 financial results on Thursday, August 4, 2022, before the opening of the U.S. financial markets. 